UNSPSC 51241260: Tacalcitol monohydrate

This classification denotes a vitamin d analog C27H44O3.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B3Q63NVN9R, chemically known as (+)-(5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,24-triol monohydrate, but more generally known as tacalcitol monohydrate, which bears US NIH Compound Identifier 9910819. European Medicines Agency schedules Tacalcitol monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22635.

Most nations, for tariff and trade purposes, schedule tacalcitol monohydrate under HS 29061900 and SITC 51231. As of Q4 2014, TACALCITOL MONOHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CC[C@H](C(C)C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C.O.

UNSPSC 51241260 Tacalcitol monohydrate is a Commodity code with minimal recent state and local procurement activity. The single recent opportunity posted under this code—a City of Tampa Fire Rescue Department ITB for medical aid supplies (Solicitation 25P00157, due April 9, 2025)—does not align with the code's nominal scope. The solicitation covers general first aid and medical supplies including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets with estimated annual quantities ranging from 1 to 2,700 units across 32 line items. Tacalcitol monohydrate is a vitamin D analog used in dermatological treatments, whereas the Tampa Fire Rescue procurement requests broad-based emergency medical supplies with no mention of specialty pharmaceuticals. The code shows no relevant recent activity beyond this mislabeled opportunity.

The geographic reach and issuing-body mix cannot be characterized from available recent opportunities. The single posted opportunity originates from Tampa, Florida, and the $100,000 budget allocation was intended for the City of Tampa Fire Rescue Department. The procurement includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) offering a 5% bid discount not to exceed $10,000, and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) with discounts not to exceed $20,000. The mismatch between the UNSPSC code definition and the actual solicitation scope suggests either a coding error in the state or local procurement system or a fundamental misalignment in how this pharmaceutical code has been applied in practice.